Home Hot keywords

Search Modes




Invion is an Australian life-sciences company focussed on transforming Photodynamic Therapy (PDT) for novel and effective treatments for cancer.


株価: IVX (ASX) A$0.01 0.00 (0.00%)
9月24日 11:50 GMT+10 - 免責事項
本部所在地: オーストラリア
設立: 2000年
Invion Limited | LinkedInのフォロワー数288人Leading the global clinical development of the Photosoft™ technology for the treatment of cancers.
2021/08/24 — Invion is a very unique ASX biotech as its cancer treatment development program is fully funded by RMW Cho through a research and development ...
2021/09/09 — Life sciences company Invion Group (ASX: IVX) is rapidly advancing its next-generation photodynamic therapy INV043 for treating numerous ...
Invion Limited, a clinical-stage life-sciences company, researches and develops photodynamic therapy for the treatment of various cancers in Australia. About ...
Revenue: AU$2.33m
Market cap: AU$77.55m
投稿: Simply Wall St
HotCopper has news, discussion, prices and market data on INVION LIMITED. Join the HotCopper ASX share market forum today for free.
Find the latest INVION LTD (IVIXF) stock quote, history, news and other vital information to help you with your stock trading and investing.
INVION LIMITED IVX. LAST PRICE. 0.014. TODAY'S CHANGE. 0.000 (0.00%). VOLUME. 136,475. BID/OFFER RANGE. $0.013 - $0.014. MARKET CAP.
Invion, a life sciences company, announces it is progressing a new Active Pharmaceutical Ingredient (API) for anti-cancer treatment.

google search trends